Literature DB >> 4265871

Mithramycin in the treatment of Paget's disease of bone.

E G Elias, J T Evans.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4265871

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


× No keyword cloud information.
  15 in total

1.  Molecular insight into substrate recognition and catalysis of Baeyer-Villiger monooxygenase MtmOIV, the key frame-modifying enzyme in the biosynthesis of anticancer agent mithramycin.

Authors:  Mary A Bosserman; Theresa Downey; Nicholas Noinaj; Susan K Buchanan; Jürgen Rohr
Journal:  ACS Chem Biol       Date:  2013-09-13       Impact factor: 5.100

2.  The management of benign bone lesions.

Authors:  T M Moore; J P Harvey
Journal:  West J Med       Date:  1976-02

3.  Chemical and morphologic alterations of rabbit bone induced by adriamycin.

Authors:  D M Young; J L Fioravanti; H M Olson; D J Prieur
Journal:  Calcif Tissue Res       Date:  1975-07-04

Review 4.  The contribution of Sir James Paget (1814-1894) to the study of rheumatic disease.

Authors:  W Buchanan
Journal:  Clin Rheumatol       Date:  1996-09       Impact factor: 2.980

5.  Investigations into the sequence-selective binding of mithramycin and related ligands to DNA.

Authors:  K R Fox; N R Howarth
Journal:  Nucleic Acids Res       Date:  1985-12-20       Impact factor: 16.971

Review 6.  Drugs for disorders of bone: pharmacological and clinical considerations.

Authors:  G R Mundy; L G Raisz
Journal:  Drugs       Date:  1974       Impact factor: 9.546

7.  How mithramycin stereochemistry dictates its structure and DNA binding function.

Authors:  Caixia Hou; Jürgen Rohr; Sean Parkin; Oleg V Tsodikov
Journal:  Medchemcomm       Date:  2019-03-28       Impact factor: 3.597

8.  Paget's disease of bone.

Authors:  E S Siris; T P Jacobs; R E Canfield
Journal:  Bull N Y Acad Med       Date:  1980-04

9.  Mithramycin SK, a novel antitumor drug with improved therapeutic index, mithramycin SA, and demycarosyl-mithramycin SK: three new products generated in the mithramycin producer Streptomyces argillaceus through combinatorial biosynthesis.

Authors:  Lily L Remsing; Ana M González; Mohammad Nur-e-Alam; M José Fernández-Lozano; Alfredo F Braña; Uwe Rix; Marcos A Oliveira; Carmen Méndez; José A Salas; Jürgen Rohr
Journal:  J Am Chem Soc       Date:  2003-05-14       Impact factor: 15.419

10.  Mithramycin therapy in Paget's disease.

Authors:  A S Russell; B C Lentle
Journal:  Can Med Assoc J       Date:  1974-02-16       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.